Yttrium-90 microspheres (TheraSphere (TM) and SIR-Spheres (TM)) for the treatment of unresectable hepatocellular carcinoma

Canadian Agency for Drugs and Technologies in Health
Record ID 32007000679
English, French
Details
Project Status: Completed
URL for project: http://cadth.ca
Year Published: 2007
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Canada
  • Device Approval
  • Infusions, Intra-Arterial
  • Microspheres
  • Treatment Outcome
  • United States
  • Brachytherapy
  • Carcinoma, Hepatocellular
  • Liver Diseases
  • Liver Neoplasms
  • Radiopharmaceuticals
  • Yttrium Radioisotopes
Contact
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name: publications@cadth.ca
Contact Email: publications@cadth.ca
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.